{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:22:38Z","timestamp":1761171758230,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.riam.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T07:50:20Z","timestamp":1544687420000},"page":"198-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aspergilosis invasora en el paciente con enfermedad oncohematol\u00f3gica"],"prefix":"10.1016","volume":"35","author":[{"given":"Carlos","family":"Solano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2018.10.001_bib0330","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: Consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2018.10.001_bib0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in intensive care unit (ICU) patients: Epidemiology and economic outcomes","volume":"13","author":"Baddley","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0340","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.riam.2018.10.001_bib0345","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.micinf.2009.07.002","article-title":"The innate immune response to Aspergillus fumigatus","volume":"11","author":"Balloy","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1016\/j.riam.2018.10.001_bib0350","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: Practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.riam.2018.10.001_bib0355","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.riam.2018.10.001_bib0360","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericinB in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: A randomized pilot study (Combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"issue":"Suppl_3","key":"10.1016\/j.riam.2018.10.001_bib0365","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0370","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/AAC.04569-14","volume":"59","author":"Cornely","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"20 Suppl","key":"10.1016\/j.riam.2018.10.001_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","volume":"3","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2018.10.001_bib0380","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0385","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0390","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0395","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","article-title":"Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity","volume":"116","author":"Cunha","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0400","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.riam.2018.10.001_bib0405","doi-asserted-by":"crossref","first-page":"e1003940","DOI":"10.1371\/journal.ppat.1003940","article-title":"Inflammatory monocytes orchestrate innate antifungal immunity in the lung","volume":"10","author":"Espinosa","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.riam.2018.10.001_bib0410","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/bjc.2012.147","article-title":"Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: A systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Ethier","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.riam.2018.10.001_bib0415","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2017.05.019","article-title":"Epidemiology of antifungal resistance in human pathogenic yeasts: Current viewpoint and practical recommendations for management","volume":"50","author":"Farmakiotis","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.riam.2018.10.001_bib0420","doi-asserted-by":"crossref","first-page":"e35675","DOI":"10.1371\/journal.pone.0035675","article-title":"Characterisation of innate fungal recognition in the lung","volume":"7","author":"Faro-Trindade","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.riam.2018.10.001_bib0425","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1128\/IAI.01551-06","article-title":"Role of neutrophils in invasive aspergillosis","volume":"74","author":"Feldmesser","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.riam.2018.10.001_bib0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0435","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0440","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002353","article-title":"How we approach combination antifungal therapy for invasive aspergillosis and mucormycosis in transplant recipients","author":"Haidar","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.riam.2018.10.001_bib0445","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","article-title":"Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies","volume":"100","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0450","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0455","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.4049\/jimmunol.1002760","article-title":"TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking","volume":"185","author":"Kasperkovitz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.riam.2018.10.001_bib0460","article-title":"Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: A post hoc analysis of the SECURE trial","author":"Kontoyiannis","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2018.10.001_bib0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/AAC.00355-18","article-title":"Primary fungal prophylaxis in hematological malignancy: A network meta-analysis of randomized controlled trials","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.riam.2018.10.001_bib0470","doi-asserted-by":"crossref","first-page":"ii29","DOI":"10.1093\/jac\/dkw393","article-title":"The current management landscape: Aspergillosis","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2018.10.001_bib0475","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky286","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: Summary of the updated recommendations from the European Conference on Infections in Leukaemia","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2018.10.001_bib0480","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.riam.2018.10.001_bib0485","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0490","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: A randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0500","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the infectious diseases working party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"97","author":"Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0510","doi-asserted-by":"crossref","first-page":"e0201459","DOI":"10.1371\/journal.pone.0201459","article-title":"Aspergillus endocarditis: Diagnostic criteria and predictors of outcome. A retrospective cohort study","volume":"13","author":"Meshaal","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.riam.2018.10.001_bib0515","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/428734","article-title":"Voriconazole for invasive bone aspergillosis: A worldwide experience of 20 cases","volume":"40","author":"Mouas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0520","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.10.001","article-title":"Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy","volume":"75","author":"Neofytos","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","article-title":"Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: A 10-year, single-center experience","volume":"15","author":"Neofytos","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0530","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00277-011-1373-2","article-title":"A prospective survey of febrile events in hematological malignancies","volume":"91","author":"Pagano","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0535","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1093\/cid\/ciw444","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0540","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","volume":"31","author":"Philpott-Howard","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2018.10.001_bib0545","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0550","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/2040620716656381","article-title":"Recent developments in the management of invasive fungal infections in patients with oncohematological diseases","volume":"7","author":"Ruhnke","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0555","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: When and how to treat","volume":"68","author":"Ruping","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.riam.2018.10.001_bib0560","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/intimm\/dxr046","article-title":"Dectin-1 and dectin-2 in innate immunity against fungi","volume":"23","author":"Saijo","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.riam.2018.10.001_bib0565","doi-asserted-by":"crossref","first-page":"e32273","DOI":"10.1371\/journal.pone.0032273","article-title":"Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary aspergillosis infection","volume":"7","author":"Sainz","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.riam.2018.10.001_bib0570","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0575","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation \u2014 a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0580","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/IDR.S65592","article-title":"Prevention of invasive fungal infections in immunocompromised patients: The role of delayed-release posaconazole","volume":"8","author":"Soysal","year":"2015","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.riam.2018.10.001_bib0585","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1371\/journal.ppat.0010042","article-title":"The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus","volume":"1","author":"Steele","year":"2005","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.riam.2018.10.001_bib0590","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00277-014-2108-y","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies, 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology","volume":"93","author":"Tacke","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.riam.2018.10.001_bib0600","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"24 Suppl","key":"10.1016\/j.riam.2018.10.001_bib0605","first-page":"e38","volume":"1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2018.10.001_bib0610","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: Prevention and prophylaxis strategy guidelines","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.riam.2018.10.001_bib0615","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/blood.V86.6.2063.bloodjournal8662063","article-title":"Antifungal prophylaxis in patients with hematologic malignancies: A reappraisal","volume":"86","author":"Uzun","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0620","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Van Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2018.10.001_bib0625","first-page":"103","article-title":"Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients","volume":"30","author":"Vazquez","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.riam.2018.10.001_bib0630","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.4049\/jimmunol.0804250","article-title":"Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus","volume":"182","author":"Werner","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.riam.2018.10.001_bib0635","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Blood and Marrow Transplant Clinical Trials Network. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.riam.2018.10.001_bib0640","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.riam.2018.10.001_bib0645","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.riam.2018.10.001_bib0650","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.1143","article-title":"Pharmacokinetic\/pharmacodynamic analysis of isavuconazole against Aspergillus spp. and Candida spp. in healthy subjects and patients with hepatic or renal impairment by monte carlo simulation","author":"Zheng","year":"2018","journal-title":"J Clin Pharmacol"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140618300627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140618300627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:06:20Z","timestamp":1761105980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140618300627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1130140618300627"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2018.10.001","relation":{},"ISSN":["1130-1406"],"issn-type":[{"type":"print","value":"1130-1406"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspergilosis invasora en el paciente con enfermedad oncohematol\u00f3gica","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}